[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condbio:von-hippel-lindau-syndrome:von-hippel-lindau-disease-tumor-suppressor":3},{"condition":4,"biomarker":5,"total":6,"trials":7},"Von Hippel Lindau Syndrome","Von Hippel-Lindau Disease Tumor Suppressor",4,[8,16,22,28],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT04924075","Belzutifan\u002FMK-6482 for the Treatment of Advanced Pheochromocytoma\u002FParaganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)",[12],"Phase 2","RECRUITING","2026-08-26T02:17:01.714035Z","2026-07-05T05:32:16.796442Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":20,"content_modified":21},"NCT04074135","Natural History and Management of Von Hippel-Lindau (VHL) Associated Pancreatic Neuroendocrine Tumors",[12],"2026-08-26T02:18:57.189473Z","2026-05-05T02:43:27.067216Z",{"nct_id":23,"title":24,"phases":25,"status":13,"updated_at":26,"content_modified":27},"NCT03749980","MyVHL: Patient Natural History Study",[],"2026-08-26T02:18:09.641312Z","2026-05-13T02:55:06.175956Z",{"nct_id":29,"title":30,"phases":31,"status":13,"updated_at":32,"content_modified":33},"NCT00001238","Von Hippel-Lindau (VHL): Clinical Manifestations, Diagnosis, Management and Molecular Bases of Inherited Renal and Other Urologic Malignant Disorders",[],"2026-08-26T02:16:34.792807Z","2026-07-05T18:42:10.720145Z"]